Bhavina Sharma MD

Articles by Bhavina Sharma MD

This trial combines pembrolizumab and trabedersen to enhance treatment for advanced NSCLC, targeting TGF-β2 for improved patient outcomes.

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC

ByOmar K. Abughanimeh, MBBS,Anthony E. Maida III, PhD, MA, MBA,Sanjive Qazi, PhD,Kate-Lynn Muir, DO,Bhavina Sharma MD,Lynette Smith, PhD,Apar Kishor Ganti, MD

October 30th 2025

Unusual Clinical Presentation of Clear Cell Sarcoma in a Young Woman

BySamia Asif, MBBS,Brendan J. Hurley, MD,Sehr Haroon, MD,Subodh Lele, MD,Bhavina Sharma MD

October 12th 2023

A young woman presents with painless lumps to the emergency department and is later diagnosed with clear cell carcinoma.

Latest Updated Articles

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC
October 30th 2025
Unusual Clinical Presentation of Clear Cell Sarcoma in a Young Woman
October 12th 2023

Trending on CancerNetwork

177Lu-Edoterotide Handed CRL by FDA For GEP-NETs Treatment

DESTINY Trials May Reshape HER2-Positive Breast Cancer Care With T-DXd

Divesiran Shows Clinical Responses in Phase 2 Polycythemia Vera Trial

BI-1808 Earns FDA Fast Track Status for Advanced Ovarian Cancer

Disease Stage/Age Among Adverse Prognostic Factors for Ovarian Germ Cell Tumors